期刊文献+

针刺对洋地黄类药物治疗心衰可能的增效减毒作用机制研究思路 被引量:6

Considerations about Study on Mechanisms of Acupuncture Underlying Efficacy-enhancement and Toxicity-attenuation of Digitalis Drugs for Heart Failure
原文传递
导出
摘要 洋地黄作为广泛使用的治疗心衰的强心药,极易引起心律失常等毒副作用。寻找促使洋地黄增效减毒的方法对提高洋地黄的疗效和安全性意义重大。研究表明,针灸可改善缺血性心脏功能损害,抑制缺血性心律失常,针灸与化疗药物联用亦可减少其毒副作用,提示针灸与洋地黄联用可能起到增效减毒的作用。针刺有可能通过调节众多与心肌细胞内钙调节相关的分子、结构或功能,抑制心衰的发展;通过改善心肌细胞肌浆网钙泵功能、提高心肌肌钙蛋白对Ca2+的敏感性,来增强心肌收缩功能,并降低洋地黄非毒性的起效浓度,从而起到对洋地黄的增效减毒作用。上述思路为针药结合治疗心衰提供了新的线索。 Digitalis glycosides, a group of cardiotonic agents for heart failure, have been used for a long time, but may often trigger arrhythmias as a result of digitalis intoxication. It is of great significance in finding a method to reduce their toxicity and improve clinical curative effects simultaneously in the application of digitalis glycosides. It has been well documented that acu- puncture has good therapeutic effects in improving cardiac function and inhibiting arrhythmia induced by myocardial ischemia. Acupuncture combined with chemotherapeutics can reduce the adverse effects of chemotherapeutics. Accordingly, acupuncture com- bined with digitalis is likely to reduce the side effects of digitalis by regulating intracellular Ca2+ , improving the function of Ca2+ - ATPase in the sarcoplasmic reticulum, increasing calcium sensitivity of cardiac troponin, etc. These considerations may provide a novel clue for treatment of heart failure by joint administration of acupuncture and drugs.
出处 《针刺研究》 CAS CSCD 北大核心 2011年第3期225-229,共5页 Acupuncture Research
基金 国家自然科学基金资助课题(No.30873295和30801485) 财政部资助中国中医科学院自主选题项目(No.ZZ2007001) 科技部"973"计划专项课题(No.2006CB504506)
关键词 针药结合 洋地黄 心力衰竭 增效减毒 Acupuncture combined with drugs Digitalis Heart failure Efficacy-enhancement and toxicity-attenuation
  • 相关文献

参考文献36

  • 1Solaro R J, Arteaga G M. Heart failure, ischemia/reperfusion injury and cardiac troponin[J]. Adv Exp Med Biol, 2007,592 (3) :191-200.
  • 2Sutton M S, Keane M G. Reverse remodeling in heart failure with cardiae resynehronisation therapy[J]. Heart, 2007, 93 (2) :167-171.
  • 3Jorde U P. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact[J]. Cardiol Rev,2006,14(2) :81-87.
  • 4Gelow J M, Fang J C. Update in the approach to and manager ment of heart failure[J]. South Med J,2006,99(12):1346-1355.
  • 5Pickett J R, Dickinson E T. Dealing with DIG. A comprehensive review of digoxin and its therapeutic and toxic effects[J]. JEMS,2005,30(8):70-78,82,84.
  • 6Ma G, Brady W J, Pollack M, et al. Electrocardiographic manifestations: digitalis toxicity[J]. J Emerg Med, 2001,20 (2) :145-152.
  • 7Demiryurek A T, Demiryurek S. Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels[J]. Auton Autacoid Pharmacol, 2005,25 (2) : 35 - 52.
  • 8Sica D A, Brath L. Angiotensin-eonverting enzyme inhibition- emerging pulmonary issues relating to cough [J]. Congest Heart Fail,2006,12(4) :223-226.
  • 9Ramanna H, Elvan A, Wittkampf F H, et al. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation[J]. J Am Coll Cardiol, 2001,37 (5): 1403- 1407.
  • 10Wang X, Wang Q, Guo W, et al. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mecha- nism through cardiac mitochondrial protection[J]. Biosei Rep,2011,31(2) :87-98.

二级参考文献172

共引文献301

同被引文献92

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部